However, many studies have revealed that a high abundance of CD4 + Th1 cells is associated with poorer prognosis in various cancers, including PDAC, consistent with our findings indicating that hypomethylation of the PD-L1 promoter correlates positively with worse survival outcomes [32, 33]. The gene discussed is CD4; the disease is cancer.